Oral budesonide in the treatment of chronic refractory pouchitis.

Abstract

BACKGROUND:

Pouchitis is the major long-term complication after ileal-pouch nal anastomosis for ulcerative colitis. Ten to 15% of patients develop a chronic pouchitis, either treatment responsive or treatment refractory.

AIM:

To evaluate the efficacy of oral budesonide in inducing remission and improving quality of life in patients with chronic refractory pouchitis.

METHODS:

Twenty consecutive patients with active pouchitis, not responding after 1 month of antibiotic treatment were treated with budesonide controlled ileal release 9 mg/day for 8 weeks. Symptomatic, endoscopic and histological evaluations were undertaken before and after treatment according to Pouchitis Disease Activity Index. Remission was defined as a combination of Pouchitis Disease Activity Index clinical score of < or = 2, endoscopic score of < or = 1 and total Pouchitis Disease Activity Index score of < or = 4. The quality of life was assessed with the Inflammatory Bowel Disease Questionnaire.

RESULTS:

Fifteen of 20 patients (75%) achieved remission. The median total Pouchitis Disease Activity Index scores before and after therapy were, respectively, 14 (range 9-16) and 3 (range 2-10) (P < 0.001). The median Inflammatory Bowel Disease Questionnaire score also significantly improved from 105 (range 77-175) to 180 (range 85-220) (P < 0.001).

CONCLUSION:

Eight-week treatment with oral budesonide appears effective in inducing remission in patients with active pouchitis refractory to antibiotic treatment in this open-label study.

• Authors: P Gionchetti, F Rizzello, G Poggioli, F Pierangeli, S Laureti, C Morselli, R Tambasco, C Calabrese, M Campieri
• Journal: Alimentary pharmacology & therapeutics (Aliment Pharmacol Ther) Vol. 25 Issue 10 Pg. 1231-6 (May 15 2007) ISSN: 0269-2813 [Print] England
• PMID: 17451569 (Publication Type: Clinical Trial, Journal Article)

Chemical References

• Anti-Bacterial Agents
• Anti-Infective Agents
• Delayed-Action Preparations
• Budesonide

Topics

• Administration, Oral
• Adult
• Anti-Bacterial Agents (therapeutic use)
• Anti-Infective Agents (administration & dosage)
• Budesonide (administration & dosage)
• Chronic Disease
• Colitis, Ulcerative (surgery)
• Delayed-Action Preparations
• Female
• Humans
• Male
• Middle Aged
• Patient Compliance
• Pouchitis (drug therapy)
• Quality of Life (psychology)
• Treatment Outcome